Hormone dependency of breast tumours developing in the Guernsey Cohort Study

Breast Cancer Research and Treatment

Volumn 97, Issue 2, 2006, Pages 205-208

  Fentiman, I S ^a   Hanby, A ^b   Allen, D S ^a   Key, T ^c   Meilahn, E N ^d  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

16hydroxyestrone; Breast cancer; Estradiol; Estrogen receptor; Risk factors

Indexed keywords

16 HYDROXYESTRONE; ESTRADIOL; ESTROGEN RECEPTOR; ESTRONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; BREAST TUMOR; COHORT ANALYSIS; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE DEPENDENCE; HORMONE URINE LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEX HORMONE DETERMINATION;

BREAST NEOPLASMS; COHORT STUDIES; ESTRADIOL; FEMALE; HUMANS; HYDROXYESTRONES; RADIOIMMUNOASSAY; RECEPTORS, ESTROGEN;

EID: 33646545360     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9113-8     Document Type: Article

References (28)

1. Bulbrook RD, Hayward JL, Spicer CC et al.: Abnormal excretion of urinary steroids by women with early breast cancer. Lancet ii: 1238-1240, 1962
2. Thomas HV, Key T, Allen DS et al.: A prospective study of endogenous serum hormone concentrations and breast cancer risk in postmenopausal women on the island of Guernsey. Br J Cancer 76: 901-905, 1997
3. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047-1059, 1997
4. Jones C, Ingram D, Mattes E et al.: The effect of hormone replacement therapy on prognostic indices in women with breast cancer. Med J Aus 161: 106-110, 1994
5. Magnusson C, Holmberg L, Norden T et al.: Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res Treat 38: 325-334, 1996
6. Li CI, Daling JR, Malone KE: Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 21: 28-34, 2003
7. Gruvberger S, Ringner M, Chen Y et al.: Estrogen receptor status in breast cancer is associated with remarkably different gene expression patterns. Cancer Res 61: 5979-5984, 2001
8. Fentiman IS, Wang DY, Allen DS et al.: Bone density of normal women in relation to endogenous and exogenous oestrogens. Br J Rheumatol 33: 808-815, 1994
9. Key TJA, Wang DY, Brown JB et al.: A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer 73: 1615-1619, 1996
10. Thomas HV, Key TJ, Allen DS et al.: A prospective study of endogenous serum hormone concentrations and breast cancer risk on the Island of Guernsey. Br J Cancer. 76: 401-405, 1997
11. Al Saati T, Clamens S, Cohen-Kanafo E et al.: Production of monoclonal antibodies to human oestrogen receptor protein (ER) using recombinant ER (RER). Int J Cancer 55: 651-65, 1993
12. Miyoshi Y, Tanji Y, Taguchi T et al.: Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women. Clin Cancer Res 9: 2229-2233, 2003
13. Zeleniuch-Jacquotte A, Toniolo P, Levitz M et al.: Endogenous estrogens and risk of breast cancer: a prospective study in postmenopausal women. Cancer Epidemiol Biomarkes Prev 4: 857-860, 1995
14. Nomura Y, Tashiro H, Hamada Y et al.: Relationship between estrogen receptors and risk factors of breast cancer in Japanese pre- and postmenopausal patients. Breast Cancer Res Treat 4: 37-43, 1987
15. Giuffrida D, Lupo L, La Porta GA, Padova G, Foti E, Marchese V: Relation between steroid receptor status and body weight in breast cancer patients. Eur J Cancer 28: 112-115, 1992
16. Harlan LC, Coates RJ, Block G et al.: Estrogen receptor status and dietary intakes in breast cancer patients. Epidemio 4: 25-31, 1993
17. Kushi LH, Potter JD, Bostick RM, Drinkard CR, Sellers TA et al.: Dietary fat and risk of breast cancer according to hormone receptor status. Epidemiol Biomarkers Prev 4: 11-19, 1995
18. Mannisto S, Pietinen P, Pyy M et al.: Body-size indicators and risk of breast cancer according to menopausal and estrogen receptor status. Int J Cancer 27: 8-13, 1996
19. Enger SM, Ross RK, Paganini-Hill A et al.: Body size, physical activity, and breast cancer hormone receptor status: results from 2 case-control studies. Cancer Epidemiol Biomarkers Prev 9: 681-687, 2000
20. Hildreth NG, Kelsey JL, Eisenfeld AJ et al.: Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. J Natl Cancer Inst 70: 1037-1031, 1983
21. Stanford JL, Szklo M, Boring CC et al.: A case-control study of breast cancer stratified by estrogen receptor status. Am J Epidemiol 125: 184-194, 1987
22. Li CI, Malone KE, Daling JR: Differences in breast cancer hormone receptor status and histology by race and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11: 601-607, 2002
23. Yoo KV, Tajima K, Miura S, Yoshida M, Kuroishi T et al.: A hospital-based case-control study of breast cancer risk factors by estrogen and progesterone receptor status. Cancer Causes Control 4: 39-44, 1993
24. Gapstur SM, Potter JD, Drinkard C, Folsom AR: Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differes by estrogen/progesterone receptor status in the IOWA women's health study. Cancer Epidemiol Biomarkers Prev 4: 313-318, 1995
25. Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C et al.: Progesterone and estrogen receptors and mammary neoplasia in the Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 4: 319-326, 1995
26. Tutera AM, Sellers TA, Potter JD, Drinkard CR, Wiesner GL, Folsom AR: Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status. Genet Epidemiol 13: 207-221, 1996
27. Enger SM, Ross RK, Paganini-Hill A et al.: Alcohol consumption and breast cancer oestrogen and progesterone receptor status. Br J Cancer 78: 1308-1314, 1999
28. Althuiss MD, Fergenbaum JH, Garcia-Closas M et al.: Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13: 1558-1568, 2004